Name: Spruce Biosciences, Inc. (SPRB) Balance Sheet
Creator: FinSpry

Spruce Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Spruce Biosciences, Inc. (SPRB) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	38.75	96.34	24.49	88.97	157.15
Short-Term Investments	0.00	0.00	54.59	46.22	0.00
Cash & Short-Term Investments	38.75	96.34	79.08	88.97	157.15
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.45	1.97	1.21	0.40	2.97
Total Current Assets	44.21	102.18	83.61	91.90	160.40
Non-Current Assets
Property, Plant & Equipment (Net)	0.93	1.18	1.40	1.48	1.87
Long-Term Investments	0.00	0.00	0.00	32.46	0.00
Other Non-Current Assets	0.07	0.58	0.64	0.65	0.62
Total Non-Current Assets	1.00	1.76	2.04	34.59	0.00
Total Assets	45.21	103.95	85.65	126.49	162.88
Current Liabilities
Accounts Payable	1.30	3.33	1.43	2.82	3.63
Short-Term Debt	1.91	1.62	1.62	0.00	2.55
Current Portion of Long-Term Debt	1.62	1.62	1.62	0.00	2.55
Accrued Liabilities	12.05	11.25	7.97	5.69	3.33
Deferred Revenue	0.00	4.91	0.00	0.00	0.00
Other Current Liabilities	12.05	14.60	9.40	6.05	0.00
Total Current Liabilities	15.25	24.47	12.45	8.87	9.76
Non-Current Liabilities
Long-Term Debt	0.86	1.72	3.29	6.17	1.92
Other Non-Current Liabilities	0.28	0.24	0.16	0.07	0.12
Total Non-Current Liabilities	1.14	2.97	4.72	6.24	0.00
Total Liabilities	16.39	27.44	17.16	15.12	13.46
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-250.27	-197.23	-149.31	-103.32	-60.84
Accumulated Other Comprehensive Income	0.00	0.00	-0.56	-0.18	0.00
Additional Paid-in Capital	279.09	273.74	218.35	214.69	0.00
Shares Outstanding	0.56	0.55	0.31	0.31	0.00
Total Stockholders' Equity	28.82	76.51	68.49	111.37	149.43
Total Liabilities & Equity	45.21	103.95	85.65	126.49	0.00